Nxera Pharma Co.,Ltd.
Loading...
Key Metrics
Market Cap
N/A
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
6.6B
Net Income
-4.8B
Gross Margin
N/A
Op. Margin
-82.4%
Net Margin
-73.5%
ROE
-7.1%
ROA
-3.6%
D/E
1.22
Dividend Yield
N/A
EPS
23.89
Current Ratio
7.01
Price History
Company Info
| Industry | PHARMACEUTICAL |
| Market Segment | Prime |
| Accounting | IFRS |
| Currency | JPY |
| Fiscal Year | 2024 |
Peers
GNI Group Ltd.
2160
--
P/E: --
Kyowa Kirin Co.,Ltd.
4151
--
P/E: --
--
P/E: --
Astellas Pharma Inc.
4503
--
P/E: --
--
P/E: --
Shionogi & Co.,Ltd.
4507
--
P/E: --
--
P/E: --
--
P/E: --
Financial Statements
Loading financials...
Open Advanced Charts
Full charting with technical indicators, candlestick, and more.
| Ticker | 4565 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |